DP001

DRUG2 trials

Sponsors

Deltanoid Pharmaceuticals

Conditions

OsteoporosisSecondary Hyperparathyroidism

Phase 2

Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density

CompletedNCT00715676

Deltanoid PharmaceuticalsOsteoporosis

Start: 2007-03-31End: 2009-01-31Updated: 2010-01-11

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

CompletedNCT01653379

Deltanoid PharmaceuticalsSecondary Hyperparathyroidism

Start: 2012-08-31End: 2014-07-31Updated: 2017-08-16